The Daily Buyout
23% stake heldStrategic acquisitionMaterials & ChemicalsCompleted

Novonesis completes MicroBioGen acquisition

Novonesis closed its acquisition of Australian yeast biotechnology firm MicroBioGen, building on a 23% stake held since 2013; all regulatory approvals were obtained.

Read the full coverage, free

We only link to sources you can read without a subscription. How we check.

More Materials & Chemicals deals